Dofetilide Patent Expiration
Dofetilide is Used for treating cardiac arrhythmia. It was first introduced by Pfizer Pharmaceuticals Production Corp Ltd
Dofetilide Patents
Given below is the list of patents protecting Dofetilide, along with the drug name that holds that patent and the company name owning that drug.
| Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
|---|---|---|---|---|
| Tikosyn | US4959366 | Anti-arrhythmic agents |
Sep 25, 2012
(Expired) | Pfizer |
| Tikosyn | US6124363 | Dofetilide polymorphs |
Oct 09, 2018
(Expired) | Pfizer |
Try Our Curated Drug Screens
Dofetilide Generics
Several generic applications have been filed for Dofetilide. The first generic version for Dofetilide was by Dr Reddys Laboratories Sa and was approved on Jun 6, 2016. And the latest generic version is by Teva Pharmaceuticals Usa Inc and was approved on Apr 15, 2022.
Given below is the list of companies who have filed for Dofetilide generic.
1. ACCORD HLTHCARE
Accord Healthcare Inc has filed for 3 different strengths of generic version for Dofetilide. Given below are the details of the strengths of this generic introduced by Accord Hlthcare.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 0.125MG | capsule | Prescription | ORAL | AB | Jun 19, 2020 |
| 0.25MG | capsule | Prescription | ORAL | AB | Jun 19, 2020 |
| 0.5MG | capsule | Prescription | ORAL | AB | Jun 19, 2020 |
2. AUROBINDO PHARMA LTD
Aurobindo Pharma Ltd has filed for 3 different strengths of generic version for Dofetilide. All of these versions come by the name DOFETILDE. Given below are the details of the strengths of this generic introduced by Aurobindo Pharma Ltd.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 0.125MG | capsule | Prescription | ORAL | AB | Jan 22, 2019 |
| 0.5MG | capsule | Prescription | ORAL | AB | Jan 22, 2019 |
| 0.25MG | capsule | Prescription | ORAL | AB | Jan 22, 2019 |
3. BIONPHARMA
Bionpharma Inc has filed for 3 different strengths of generic version for Dofetilide. Given below are the details of the strengths of this generic introduced by Bionpharma.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 0.125MG | capsule | Prescription | ORAL | AB | Apr 10, 2018 |
| 0.5MG | capsule | Prescription | ORAL | AB | Apr 10, 2018 |
| 0.25MG | capsule | Prescription | ORAL | AB | Apr 10, 2018 |
4. DR REDDYS LABS SA
Dr Reddys Laboratories Sa has filed for 3 different strengths of generic version for Dofetilide. Given below are the details of the strengths of this generic introduced by Dr Reddys Labs Sa.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 0.125MG | capsule | Prescription | ORAL | AB | Jun 6, 2016 |
| 0.25MG | capsule | Prescription | ORAL | AB | Jun 6, 2016 |
| 0.5MG | capsule | Prescription | ORAL | AB | Jun 6, 2016 |
5. GRANULES
Granules Pharmaceuticals Inc has filed for 3 different strengths of generic version for Dofetilide. Given below are the details of the strengths of this generic introduced by Granules.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 0.5MG | capsule | Prescription | ORAL | AB | Oct 14, 2021 |
| 0.25MG | capsule | Prescription | ORAL | AB | Oct 14, 2021 |
| 0.125MG | capsule | Prescription | ORAL | AB | Oct 14, 2021 |
6. MSN
Msn Laboratories Private Ltd has filed for 3 different strengths of generic version for Dofetilide. Given below are the details of the strengths of this generic introduced by Msn.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 0.5MG | capsule | Prescription | ORAL | AB | Jan 29, 2020 |
| 0.25MG | capsule | Prescription | ORAL | AB | Jan 29, 2020 |
| 0.125MG | capsule | Prescription | ORAL | AB | Jan 29, 2020 |
7. NOVAST LABS
Novast Laboratories Ltd has filed for 3 different strengths of generic version for Dofetilide. Given below are the details of the strengths of this generic introduced by Novast Labs.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 0.125MG | capsule | Discontinued | ORAL | N/A | Dec 27, 2019 |
| 0.25MG | capsule | Discontinued | ORAL | N/A | Dec 27, 2019 |
| 0.5MG | capsule | Discontinued | ORAL | N/A | Dec 27, 2019 |
8. PRINSTON INC
Prinston Pharmaceutical Inc has filed for 3 different strengths of generic version for Dofetilide. Given below are the details of the strengths of this generic introduced by Prinston Inc.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 0.5MG | capsule | Discontinued | ORAL | N/A | Dec 17, 2019 |
| 0.125MG | capsule | Discontinued | ORAL | N/A | Dec 17, 2019 |
| 0.25MG | capsule | Discontinued | ORAL | N/A | Dec 17, 2019 |
9. RK PHARMA
Rk Pharma Inc has filed for 3 different strengths of generic version for Dofetilide. Given below are the details of the strengths of this generic introduced by Rk Pharma.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 0.25MG | capsule | Discontinued | ORAL | N/A | Apr 14, 2022 |
| 0.5MG | capsule | Discontinued | ORAL | N/A | Apr 14, 2022 |
| 0.125MG | capsule | Discontinued | ORAL | N/A | Apr 14, 2022 |
10. SIGMAPHARM LABS LLC
Sigmapharm Laboratories Llc has filed for 3 different strengths of generic version for Dofetilide. Given below are the details of the strengths of this generic introduced by Sigmapharm Labs Llc.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 0.125MG | capsule | Prescription | ORAL | AB | Mar 26, 2018 |
| 0.25MG | capsule | Prescription | ORAL | AB | Mar 26, 2018 |
| 0.5MG | capsule | Prescription | ORAL | AB | Mar 26, 2018 |
11. STRIDES PHARMA
Strides Pharma Global Pte Ltd has filed for 3 different strengths of generic version for Dofetilide. Given below are the details of the strengths of this generic introduced by Strides Pharma.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 0.125MG | capsule | Prescription | ORAL | AB | Oct 9, 2018 |
| 0.25MG | capsule | Prescription | ORAL | AB | Oct 9, 2018 |
| 0.5MG | capsule | Prescription | ORAL | AB | Oct 9, 2018 |
12. SUN PHARM
Sun Pharmaceutical Industries Ltd has filed for 3 different strengths of generic version for Dofetilide. Given below are the details of the strengths of this generic introduced by Sun Pharm.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 0.5MG | capsule | Prescription | ORAL | AB | Oct 9, 2018 |
| 0.125MG | capsule | Prescription | ORAL | AB | Oct 9, 2018 |
| 0.25MG | capsule | Prescription | ORAL | AB | Oct 9, 2018 |
13. TEVA PHARMS USA
Teva Pharmaceuticals Usa Inc has filed for 3 different strengths of generic version for Dofetilide. Given below are the details of the strengths of this generic introduced by Teva Pharms Usa.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 0.25MG | capsule | Discontinued | ORAL | N/A | Apr 15, 2022 |
| 0.5MG | capsule | Discontinued | ORAL | N/A | Apr 15, 2022 |
| 0.125MG | capsule | Discontinued | ORAL | N/A | Apr 15, 2022 |